Acceptance and Commitment Therapy for patients with primary insomnia - a pilot study

Not Applicable

Conditions: F51.0
Nonorganic insomnia

Registration Number: DRKS00004443

Lead Sponsor: niversitätsklinikum FreiburgUniversitätsklinik für Psychiatrie und PsychsomatikAbteilung für Psychiatrie und Psychotherapie

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Pending

Sex: All

Target Recruitment: 12

Inclusion Criteria

1.meet diagnostic criteria for primary insomnia according to DSM-IV (American Psychiatric Association (APA), 1994) as assessed by experienced sleep clinicians based on a clinical interview including clinical sleep history and standard physical examinations

2.duration of insomnia for at least 6 months

3.insomnia at a clinical level, defined as a sleep onset latency or wakefulness after sleep onset of more than 30 minutes at least 3 times a week (Buysse et al., 2006)

4.previous unsuccessful treatment attempts: Patients who previously underwent CBT, including relaxation, sleep restriction, stimulus control, sleep hygiene and still fulfill criteria 1 to 3 at baseline will be included.

5.written informed consent after a detailed description of the study

6.age between 18 and 65 years

Exclusion Criteria

1.other sleep disorders requiring other treatment, e.g. sleep apnea (AHI>10/h), restless legs syndrome, periodic limb movement disorder (PLMS index with arousal >5/h), narcolepsia or circadian rhythm disorders
2.relevant medical or psychiatric comorbidity, i.e. only patients who do not currently fulfill the diagnostic criteria for another disorder are eligible. Patients with a history of psychosis, affective disorder, substance abuse or dependency, borderline personality disorder or other relevant mental disorder will be excluded.
3.evidence of mental retardation, severe cognitive deficits and neurological disorders
4.concomitant other psychotherapy
5.any psychoactive medication, including benzodiazepines, benzodiazepine-receptor agonists, antidepressants, antipsychotics etc.

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
participants' subjective satisfaction with the intervention, measured by a) the Insomnia Treatment Satisfaction Survey and an ACT-specific treatment satisfaction scale,<br>administered after the intervention and b) a measure of process quality (Berner Stundenbogen) administered<br>after every therapy session

Secondary Outcome Measures